MLSS vs NVST

For growth investors, Envista Holdings Corp (NVST) is the stronger pick with 8.

3% revenue growth year-over-year, versus -12. 2% for Milestone Scientific Inc. (MLSS). Envista Holdings Corp (NVST) offers the better valuation at 86. 7x trailing P/E (17. 2x forward), making it the more compelling value choice. Analysts rate Envista Holdings Corp (NVST) a "Hold" — based on 19 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Envista Holdings Corp (NVST) delivered a total return of -46.

6%, compared to -80. 9% for Milestone Scientific Inc. (MLSS). Over 10 years, the gap is even starker: NVST returned -13. 1% versus MLSS's -79. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Milestone Scientific Inc.

(MLSS) is the lower-risk stock at 0. 94β versus Envista Holdings Corp's 1. 65β — meaning NVST is approximately 75% more volatile than MLSS relative to the S&P 500. On balance sheet safety, Milestone Scientific Inc. (MLSS) carries a lower debt/equity ratio of 6% versus 55% for Envista Holdings Corp — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Envista Holdings Corp (NVST) is pulling ahead at 8.

3% versus -12. 2% for Milestone Scientific Inc. (MLSS). On earnings-per-share growth, the picture is similar: Envista Holdings Corp grew EPS 104. 3% year-over-year, compared to 37. 9% for Milestone Scientific Inc.. Over a 3-year CAGR, NVST leads at 1. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Envista Holdings Corp (NVST) is the more profitable company, earning 1.

7% net margin versus -54. 6% for Milestone Scientific Inc. — meaning it keeps 1. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NVST leads at 8. 3% versus -78. 3% for MLSS. At the gross margin level — before operating expenses — MLSS leads at 74. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Milestone Scientific Inc.

(MLSS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 94)). Envista Holdings Corp (NVST) carries a higher beta of 1. 65 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MLSS: -79. 9%, NVST: -13. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.